Category Archives: Cbd Oil

TipRanks

Expectations of good news on the near horizon are buoying markets right now. Over the past month, both the S&P 500 and the NASDAQ are up 11% to new record highs.Investors are excited at the prospect of a COVID vaccine coming before the winter is out. And the electoral results, that Democrat Joe Biden will ascend to the Presidency while the Republicans will emerge strengthened in Congress, promise the avoidance of extremes typical of divided government. In short, investors are looking forward to return to normal environment over the next several months. And that has them seeking stocks that are primed for gains. Against this backdrop, Goldman Sachs analysts are pounding the table on three stocks in particular, noting that each could surge over 40% in the year ahead. After running both tickers through TipRanks database, we found out that the rest of the Street is also standing squarely in the bull camp.Codiack BioSciences (CDAK)As we have all learned from coronavirus pandemic, some new thing in medical science can make huge impact on our world. Codiack aims to turn that principle to good. This research-oriented pharmaceutical aims to turn exosome therapeutics into a whole new class of medicines. Exosomes are the degradation mechanism RNA, and can transfer genetic material around a body.And therein lies the potential. Codiack has developed a design platform for the engineering of exosome proteins capable of carrying and protecting drug molecules through cell walls. In effect, the proteins will mimic the pathways used by viruses but are non-viral, and are designed to carry a payload of therapeutic agents. If successful, exosome therapy offers doctors the ability to design a drug that will deliver specific agents to specific cells to fight specific disease.Codiack is involved in all aspects of exosome therapeutics, from design to manufacturing, and currently has an active pipeline of agents seven, in all in various stages of discovery, preclinical testing, and the beginnings of Phase 1 trials.In the biosciences, success or failure is all about that pipeline, and in its diverse, active pipeline of agents in a new sector of biotechnological pharmaceuticals, Codiack has a fine resource to attract investors. To get those investors, the company went public this past October, selling 5.5 million shares at an opening price of $14.10 per share.Among the healthcare name's fans is Goldman Sachs analyst Graig Suvannavejh. The analyst wrote, Biopharma industry interest in exosomes has long been high, but engineering them for a specific function and manufacturing at scale have both proven challenging. Among a field of multiple competitors, CDAK has made the most significant progress on both fronts, and as such we view their technology platform as best-in-class."Given share underperformance (-37%) since the IPO, we find risk/reward highly compelling at current levels, and with key 2021 data sets to provide potential de-risking and positive share inflection," the analyst concluded.Suvannavejh rates CDAK a Buy, and his $29 price target shows the extent of his confidence it implies a 222% upside for the coming year. (To watch Suvannavejhs track record, click here)Overall, Codiack has a Strong Buy from the analyst consensus 3 reviewers have put up Buy ratings in recent weeks. The stock is selling for $8.90, and its $24 average price target implies a 166% one-year upside potential. (See CDAK stock analysis on TipRanks)Arcutis Biotherapeutics (ARQT)Acrutis is a pioneering researcher in the treatment of dermatological disease. Arcutis is involved in discovering the next generation of dermatological treatments an important niche, especially when one realizes that one common ailment, psoriasis, has not seen an FDA approval for a novel treatment in over two decades.The company is leveraging recent advances in immunology and inflammation to find new approaches to skin treatment. The goal is to make it easier for patients and doctors together to manage conditions like psoriasis, alopecia, atopic dermatitis, seborrheic dermatitis, and vitiligo, to name just a few.The company's lead candidate, ARQ-151 (roflumilast cream), is about to enter a phase 3 trial for atopic dermatitis, and is in an advanced phase 3 stage in Plaque Psoriasis. Arcutis has recently issued an update on positive data from the Phase 2 trials of ARQ-151 in atopic dermatitis. The drug is a once-daily treatment, and has demonstrated significant patient relief from symptoms, especially itching and itching-related sleep problems. This is another stock in Suvannavejhs coverage universe. The Goldman analyst is impressed by developments in the companys pipeline work, noting: ARQT provided an update on the outcome of its end-of-Phase 2 meetings with the FDA, following their Phase 2a trial of ARQ-151 in atopic dermatitis (AtD). Feedback from regulators was broadly encouraging, in particular, acknowledging the robust long-term safety data being generated by ARQT for ARQ-151 in plaque psoriasisAccordingly, Suvannavejh rates ARQT a Buy, and sets a $36 price target that indicates room for 40% upside growth in 2021. (To watch Suvannavejhs track record, click here)Arcutis has 2 recent Buy reviews, making the consensus rating a Moderate Buy. The stocks average price target is $37, suggesting a 44% upside from current levels. (See ARQT stock analysis on TipRanks)Oak Street Health (OSH)With the last stock, we move from medical research to medical care. Specifically, Oak Street Health is a primary care clinic operator, and part of the Medicare Network. The company has operations and clinics in Illinois, Indiana, Michigan, Pennsylvania, and Ohio, along with New York, North Carolina, Rhode Island, Tennessee, and Texas. It has been in operation for eight years, and went public this past summer, holding the IPO in August.In the third quarter, the companys first as a publicly traded entity, OSH brought in $217.9 million in revenue. The revenue number was up 56% from the year-ago quarter. Earnings per share matched expectations, at 15 cents.The companys expansion proceeds apace, and in October, Oak Street entered New York by opening, in Brooklyn, its 70th location. A planned expansion in Texas, involving a partnership with Walmart, is also proceeding as planned, and Oak Street has opened its first Walmart Community Clinic the Dallas-Fort Worth area city of Carrollton.Robert Jones, covering this stock for Goldman, set a $74 price target to back his Buy rating. At currently levels, this target implies an upside of ~58% in the next 12 months. (To watch Jones track record, click here)Results suggest operations are still on track, with few incremental updates since the 2Q call, where management noted a resumption of center openings, (pivoted) marketing efforts, and in-person visits despite COVID. In 3Q, OSH opened 13 new centers and is on track for 73-75 by end of year The company maintained that it is continuing to operate at a high level in places with elevated COVID case counts like Chicago and Detroit, Jones noted.All in all, the Strong Buy analyst consensus rating OSH is based on 8 reviews, breaking down to 7 Buys and just a single Hold. The stock is selling for $46.94, and its $61.29 average price target suggests it has a ~31% upside for the coming year. (See OSH stock analysis on TipRanks)To find good ideas for healthcare stocks trading at attractive valuations, visit TipRanks Best Stocks to Buy, a newly launched tool that unites all of TipRanks equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

Read more here:

Opportunities and Trends in the North American Cannabidiol (CBD) Drinks Market - Market Data, Key Developments, Historic Data from 2018 and Forecasts...

Cannabidiol (CBD) is just one of the many cannabinoid compounds present in cannabis. Although its not a wonder cure, according to scientific evidence, certain advantages could theoretically be had by consuming the compound.

You already may have learned some things about how CBD can help ease pain and enhance sleep. Did you know, however, that organic CBD may help with dementia as well?

Dementia produces a series of associated symptoms that affect the capacity to perform daily tasks, including gradual impairments of memory, perception, and actions. There are multiple types of dementia. Among these, Alzheimers remains the most common. Some of the symptoms of dementia may include mood changes, difficulty with processing thoughts, agitation, depression and even psychosis.

The widely used treatments for Alzheimers disease are only effective at slowing the signs of dementia in becoming worse. The development of this disease cant be stopped completely and, over anything, its a means to better the quality of lives of individuals and their loved ones. Lately, theres been some expectation awarded to members of the Alzheimers community and their health professionals since its believed that cannabinoids play a massive role in reducing the damaging symptoms of this degenerative disorder.

Cannabinoids and cannabinoid receptors impact a specific portion of the brain called the endocannabinoid system. This complex internal bit of equipment contains two receptors: CB1 and CB2. CB1 is within every portion of the brain, including the hippocampus, which is accountable to our memory functioning and learning capacity. CB2 receptors reside in some immune cells in our mind known as microglia

While its been argued that dementia is cured by CBD, sadly, dementia currently has no cure nor can the course of the disease be changed. CBD, however, may help relieve some of the disease-related unpleasant signs and symptoms. It is not crystal clear if CBD improves dementia, but according to Medical Cannabis for the Treatment of Dementia: A Review of Clinical Effectiveness and Guidelines CBD associates with neurotransmitters that are responsible for the production of neuropsychiatric symptoms or have some degree of involvement.

Tackling the Signs of dementia

Research does suggest that high levels of CBD oil may be practical for managing a few of the signs of dementia such as agitation and stress. A few small clinical trials have evaluated the effects of cannabinoids (like THC and synthetic cannabinoids on behavioral signs of dementia.

However, trials and studies so far have been small or low quality which makes it hard to come to a conclusion. It is also essential to remember that the researchers in such studies have used high concentrations of CBD oil which may not be available to buy. These studies also have been short term therefore that we still dont understand what the long term effects of using CBD petroleum might be.

Alzheimers Society hasnt funded research into cannabis and dementia risk, or into cannabis as a possible treatment for dementia disorders.

This is only because we havent obtained any high quality software from researchers planning to investigate these difficulties.

This Upgrade is by CBD Mag from Organic-Scientific.

Our Site provides a comprehensive summary of everything organic CBD-related And can be designed to concurrently introduce folks to the ever-growing world of CBD and its health benefits, in Addition to provide existing users the most recent Details and improvements as natural CBD and all pure CBD gains adoption. For more information on organic CBD capsules, please visit our website.

CBD comes in several types. It may be inhaled or taken in capsule structure like acrylic, to mention merely a couple of choices. Many CBD patients favor non-inhalable possibilities, including CBD-rich cannabis petroleum products which could be consumed orally (like gel caps), squeezed beneath the tongue (using liquid dropper) or delivered through stains on skin (such as Band-Aids). The effects of orally administered CBD may last for as much as 4 hours, along with the start of effects has revealed to choose between 30-90 seconds.

In instances of severe symptoms that require prompt care, inhalation of focused CBD-rich cannabis effects could be felt in 2-3 minutes and continue around 1 or two hours. Inhalation could be accomplished either via smoking of CBD-rich cannabis blossom or via progressively popular vaporizer pen. Both kinds are frequently accessible medical marijuana dispensaries.

CBD oil to cardiovascular disease

Impaired blood flow into the mind precipitates issues with reasoning, memory and judgment for people having this kind of dementia. Activity from the brain tissues improved while damage to the tissues diminished, according to investigators.

Final Thoughts

CBD oil has got the interest of the public in addition to that of important associations, including one committed to encouraging Alzheimers disease sufferers. Though the Alzheimers Disease of the United Kingdom claims there is not any evidence for the preventing or slowing of dementia via CBD petroleum, the firm does say that Cannabidiol can be useful in managing different symptoms.

See the article here:

Could CBD be useful in treating dementia? - The Leaf Online

Cannabidiol (CBD) oil has been known for many health benefits, but did you know there are ways CBD affects your weight as well? The cannabinoid has been the topic of debate for years. Some say its pros outweigh the possible cons. Others argue that there is not enough scientific evidence to prove or dispute these health claims, so the point was moot.

Photo by Natasha Spencer from Pexels

Nevertheless, it hasnt stopped health enthusiasts from giving this compound a chance. Originating from cannabis plants, hemp plants, to be specific, CBD oil is most commonly and effectively used as a supplement. It could ease anything from minor pains to moderate and chronic symptoms.

However, most people know very little about CBD oil for weight loss. Understandable, given that the cannabinoid is usually used for things like body pains, anxiety, and sleep disorders. If youre planning on starting your CBD journey soon, heres your chance to discover the many wonders of this hemp oil extract, including how it can affect your body weight.

The science behind how CBD works is still under work. Some researches and studies have found great potential for the compounds healing and medicinal properties. However, none have found concrete evidence, hence, the heated debates over its legality in recent years.

Photo by Natasha Spencer from Pexels

There is even less substantiated scientific evidence of the former influencing the latter regarding CBD and weight loss. However, experts have found that while CBD may not cause weight loss or gain, it could affect factors that would lead to a significant difference in the bodyweight of users. Lets take a look at some of the ways CBD affects your weight.

The endocannabinoid system (ECS) of the human body is designed with millions of neurotransmitters regulating various parts and systems teamwork. It acts as a traffic guide for the different tissues, nerves, and muscles in the body to work accordingly.

Recent studies found that the body reacts to cannabinoids precisely because it produces its own. When CBD interacts with the ECS receptors, it helps regulate pretty much everything, including the metabolic system. As a result, when your metabolism is at its optimal condition, bodyweight is less likely to fluctuate. Losing or gaining weight could be made more accessible.

One leading cause of eating disorders is an individuals appetite. Whether your dilemma is having a voracious affinity for food or being extremely sensitive and picky about your meals, CBD products like Broad-spectrum CBD gummies for weight gain or loss could help with that. While psychoactive compounds like THC are considered a stimulant, CBD is somewhat the opposite.

It still goes back to the ECS, as CBD improves the bodys sensitivity to its needs. The cannabinoid helps us achieve homeostasis or balance, thus, curbing or increasing hunger levels according to what the body needs.

If youre planning to use CBD for weight loss, studies indicate that the compound can turn white, bad fats into brown, good fats. The former is a form of fat that can cause many chronic conditions related to overly excessive weight. Brown fats are a more active form of fats as they burn off calories by generating heat.

The more brown fats you have, the more calories you burn. With CBDs aid converting the bad fats into better ones, cannabis users are more likely to lose weight faster and with fewer complications as the process is as natural as weight loss methods go.

As mentioned before, CBD works with the body by helping its receptors regulate everything to obtain and maintain an overall balance of well-being. The compound influences the bodys CB1 and CB2 receptors responsible for regulating several vital systems, including the nervous central, digestive, respiratory, and immune systems.

People who have hormone disorders such as high cholesterol, diabetes, ovarian conditions, and many others suffer from an irregular production of much-needed compounds in the body. While CBD may not produce it directly, the hemp oil extract could help the neurotransmitters be more receptive so that it allows the body to produce adequate amounts of the hormones it needs.

One of CBDs most popular uses is to relieve symptoms of stress and anxiety. These include nerves, restlessness, jitters, palpitations, nausea, and a dozen others. For some, stress and anxiety are also the source of their weight loss or gain. It affects appetite and body functions like metabolism and digestion.

Once taken, the effects of CBD for anxiety can help these neurotransmitters be more sensitive to hormones naturally produced by the body. These include adenosine and serotonin, otherwise known as happy hormones, as they give you a good boost in mood and energy. CBDs relaxing effects soothe its users enough to have you on your feet and continue with your daily routine.

As a word of caution, be sure to consult with a physician first before making drastic changes to your diet and adding foreign substances like CBD to the mix. Also, note that while the cannabinoid has plenty of supposed health benefits, it is by no means a replacement for any prescription medications.

See the rest here:

5 Ways CBD affects your weight - The Leaf Online

To have best level of market insights and knowhow of the most excellent market opportunities into the specific markets, Hemp Oil Marketresearch report is an ideal key. It makes available statistics on the current state of the industry and hence works as a valuable source of guidance and direction for companies and investors interested in this market. As businesses can attain thorough insights with this report, they can self-assuredly make decisions about their production and marketing strategies.

What is more, an influential HEMP OIL report gives details about historic data, present market trends, future product environment, marketing strategies, technological innovation, upcoming technologies, emerging trends or opportunities, and the technical progress in the related industry. Global hemp oil market is set to witness a healthy CAGR of 35.87% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Rising use of hemp oil in skin care products and rising awareness about the medical benefits of hemp oil are the factor for the growth of this market.

To Access PDF SAMPLE REPORT, Click Here:https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-hemp-oil-market&SB

to Avail deep insights of Hemp Oil Market Size, competition landscape is provided i.e. Revenue Analysis (M $US) by Company (2017-2019), Segment Revenue Market Share (%) by Players (2017-2019) and further a qualitative analysis is made towards market concentration rate, product/service differences, new entrants and the technological trends in future.

Top Key Players Included in This Report:Isodiol International Inc, HempLife Today, Hemp Oil Canada Inc, Medical Marijuana, Inc., FOLIUM BIOSCIENCES, CV Sciences, Inc., Pharmahemp d.o.o., Gaia Botanicals, LLC, Canazil, Kazmira, Spring Creek Labs, Cavendish Nutrition Fulfillment LLC, Dr. Hemp Me., QC Infusion, Hemp Production Services, Hudson Valley Hemp, LLC., Green Roads, Royal CBD, Moon Mother Hemp Company, CBD Oil Europe, , King CBD Company and others.

Hemp oil is usually derived by pressing the hemp seeds. Hemp seed oil, hemp essential oil and CBD oil are some of the common types of the hemp oil. This oil consists of required fatty acids, antioxidants and nutraceuticals. They are very beneficial for the health as they have the ability to provide relief from problems such as chronic pain, sleeping disorders, anxiety and others. They are also used for healing and massage treatments as well. These hemp oils are widely used in applications such as cosmetic products, food and beverages, pharma and nutraceuticals and others.

Why the Hemp Oil Market Report is beneficial?

For More Enquiry Please ask Out Expert At:https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-hemp-oil-market&SB

Conducts Overall HEMP OIL Market Segmentation:

By Product Type (CBD Oil, Hemp Essential Oil, Hemp Seed Oil),

Application (Personal Care Products, Pharma and Nutraceuticals, Food and Beverages, Industrial Uses)

Key Developments in the Market:

Key Focus Areas in the Report:

Hemp Oil Market Size and Forecast 2020 2026

Impact of COVID-19 on the demand and supply in the Hemp Oil Market

Major Developments in the Hemp Oil Industry

Market Dynamics Impacting the Hemp Oil Industry

Competitive Landscape of Hemp Oil Industry

The positioning of Major Market Participants in the Hemp Oil Industry

Key Market Trends and Future Growth Prospects of the Hemp Oil Market

Hemp Oil Market Revenue and Forecast, by Type, 2020 2026

Hemp Oil Market Revenue and Forecast, by Application, 2020 2026

Hemp Oil Market Revenue and Forecast, by End-use, 2020 2026

Hemp Oil Market Revenue and Forecast, by Geography, 2020 2026

Browse Table of Content with Facts and Figures of Market Report athttps://www.databridgemarketresearch.com/toc/?dbmr=global-hemp-oil-market&SB

About Data Bridge Market Research:

Data Bridge Market ResearchPvtLtdis a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.

We provide a variety of services such as market verifiedindustry reports, technology trend analysis, Formative market research,strategic consulting, vendor analysis, production and demand analysis, consumer impact studies among many others.

Contact Us

US: +1 888 387 2818UK: +44 208 089 1725Hong Kong: +852 8192 7475Email corporatesales@databridgemarketresearch.com

Continued here:

Hemp Oil Market (COVID-19 Analysis): Indoor Applications Projected to be the Most Attractive Segment during 2020-2026 - The Courier

CBD Oil in Beauty Products Market describes an in-depth evaluation and professional study on the present and future state of the CBD Oil in Beauty Products market across the globe, including valuable facts and figures. CBD Oil in Beauty Products Market provides information regarding the emerging opportunities in the market & the market drivers, trends & upcoming technologies that will boost these growth trends. The report provides a comprehensive overview including Definitions, Scope, Application, Production and CAGR (%) Comparison, Segmentation by Type, Share, Revenue Status and Outlook, Capacity, Consumption, Market Drivers, Production Status and Outlook and Opportunities, Export, Import, Emerging Markets/Countries Growth Rate. The report presents a 360-degree overview of the competitive landscape of the industries. The CBD Oil in Beauty Products market report assesses the key regions (countries) promising a huge market share for the forecast period.

Top Key players of CBD Oil in Beauty Products Market Covered In The Report:CBD American ShamanPharmaHempGaia BotanicalsElixinolCharlottes WebApothecannaVertlyENDOCACV SciencesCannukaNuLeaf NaturalsCBD For LifeCanopy Growth CorporationAurora Cannabis (AC)Folium BiosciencesCannoidIsodiolMedical MarijuanaIRIE CBDMyaderm

Key Market Segmentation of CBD Oil in Beauty Products:

on the basis of types, the CBD Oil in Beauty Products market from 2015 to 2026 is primarily split into:

Facial creamLotionOil

on the basis of applications, the CBD Oil in Beauty Products market from 2015 to 2026 covers:

Skin diseaseSkin care

The CBD Oil in Beauty Products report gives detail complete examination to territorial sections that covered The USA, Europe, Japan, China, India, Southeast Asia, South America, South Africa, and Rest of World in Global Outlook Report with CBD Oil in Beauty Products Market definitions, characterizations, delivering reports, cost structures, advancement strategies, and plans. The results and information are top notches in the CBD Oil in Beauty Products report utilizing outlines, diagrams, pie graphs, and other pictorial portrayals concerning its Current Trends, Dynamics, and CBD Oil in Beauty Products Business Scope, Key Statistics and CAGR Analysis of top key players.

Buy Latest Copy of Report Now! @ https://www.qurateresearch.com/report/buy/RCG/global-cbd-oil-in-beauty-products-market/QBI-MR-RCG-863813/

Key Highlights from CBD Oil in Beauty Products Market Study:

Income and Sales Estimation Historical Revenue and deals volume is displayed and supports information is triangulated with best down and base up ways to deal with figure finish market measure and to estimate conjecture numbers for key areas shrouded in the CBD Oil in Beauty Products report alongside arranged and very much perceived Types and end-utilize industry. Moreover, macroeconomic factor and administrative procedures are discovered explanation in CBD Oil in Beauty Products industry advancement and perceptive examination.

Assembling Analysis The CBD Oil in Beauty Products report is presently broke down concerning different types and applications. The CBD Oil in Beauty Products market gives a section featuring the assembling procedure examination approved by means of essential data gathered through Industry specialists and Key authorities of profiled organizations.

Competition Analysis CBD Oil in Beauty Products Leading players have been considered relying upon their organization profile, item portfolio, limit, item/benefit value, deals, and cost/benefit.

Demand and Supply and Effectiveness CBD Oil in Beauty Products report moreover gives support, Production, Consumption and (Export and Import).

Which prime data figures are included in the report? -Market size (Last few years, current and expected)-Market share analysis as per different companies)-Market forecast)-Demand)-Price Analysis)-Market Contributions (Size, Share as per regional boundaries)

Who all can be benefitted out of this report? -Market Investigators-Teams, departments, and companies-Competitive organizations-Individual professionals-Vendors, Buyers, Suppliers-Others

What are the crucial aspects incorporated in the report? -Industry Value Chain-Consumption Data-Market Size Expansion-Key Economic Indicators

Strategic Points Covered in TOC:

Chapter 1: Introduction, market driving force product scope, market risk, market overview, and market opportunities of the global CBD Oil in Beauty Products market.

Chapter 2: Evaluating the leading manufacturers of the global CBD Oil in Beauty Products market which consists of its revenue, sales, and price of the products.

Chapter 3: Displaying the competitive nature among key manufacturers, with market share, revenue, and sales.

Chapter 4: Presenting global CBD Oil in Beauty Products market by regions, market share and with revenue and sales for the projected period.

Chapter 5, 6, 7, 8 and 9: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.

Contact Us:

Web:www.qurateresearch.comE-mail:[emailprotected]Ph: US +13393375221

Follow Us @

LinkedIn

Twitter

Note: In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

See the original post here:

CBD Oil in Beauty Products Market 2020 | Business Outlook, Growth, Revenue and Forecasts 2026 | COVID19 Impact Analysis with Top Key Players: CBD...

Hemp Derived CBD Oil Market describes an in-depth evaluation and professional study on the present and future state of the Hemp Derived CBD Oil market across the globe, including valuable facts and figures. Hemp Derived CBD Oil Market provides information regarding the emerging opportunities in the market & the market drivers, trends & upcoming technologies that will boost these growth trends. The report provides a comprehensive overview including Definitions, Scope, Application, Production and CAGR (%) Comparison, Segmentation by Type, Share, Revenue Status and Outlook, Capacity, Consumption, Market Drivers, Production Status and Outlook and Opportunities, Export, Import, Emerging Markets/Countries Growth Rate. The report presents a 360-degree overview of the competitive landscape of the industries. The Hemp Derived CBD Oil market report assesses the key regions (countries) promising a huge market share for the forecast period.

Top Key players of Hemp Derived CBD Oil Market Covered In The Report:CV SciencesNuLeaf NaturalsCBD American ShamanElixinol Global LimitedENDOCAMedical Marijuana IncCura CannabisIsodiol International Inc.Canopy Growth CorporationCharlottes Web Holdings, Inc.Green Roads

Key Market Segmentation of Hemp Derived CBD Oil:

on the basis of types, the Hemp Derived CBD Oil market from 2015 to 2026 is primarily split into:

Food GradePharmaceutical Grade

on the basis of applications, the Hemp Derived CBD Oil market from 2015 to 2026 covers:

CBD NutraceuticalCBD VapesCBD CosmeticsCBD Medical

The Hemp Derived CBD Oil report gives detail complete examination to territorial sections that covered The USA, Europe, Japan, China, India, Southeast Asia, South America, South Africa, and Rest of World in Global Outlook Report with Hemp Derived CBD Oil Market definitions, characterizations, delivering reports, cost structures, advancement strategies, and plans. The results and information are top notches in the Hemp Derived CBD Oil report utilizing outlines, diagrams, pie graphs, and other pictorial portrayals concerning its Current Trends, Dynamics, and Hemp Derived CBD Oil Business Scope, Key Statistics and CAGR Analysis of top key players.

Buy Latest Copy of Report Now! @ https://www.qurateresearch.com/report/buy/CnM/global-hemp-derived-cbd-oil-market/QBI-MR-CnM-817034/

Key Highlights from Hemp Derived CBD Oil Market Study:

Income and Sales Estimation Historical Revenue and deals volume is displayed and supports information is triangulated with best down and base up ways to deal with figure finish market measure and to estimate conjecture numbers for key areas shrouded in the Hemp Derived CBD Oil report alongside arranged and very much perceived Types and end-utilize industry. Moreover, macroeconomic factor and administrative procedures are discovered explanation in Hemp Derived CBD Oil industry advancement and perceptive examination.

Assembling Analysis The Hemp Derived CBD Oil report is presently broke down concerning different types and applications. The Hemp Derived CBD Oil market gives a section featuring the assembling procedure examination approved by means of essential data gathered through Industry specialists and Key authorities of profiled organizations.

Competition Analysis Hemp Derived CBD Oil Leading players have been considered relying upon their organization profile, item portfolio, limit, item/benefit value, deals, and cost/benefit.

Demand and Supply and Effectiveness Hemp Derived CBD Oil report moreover gives support, Production, Consumption and (Export and Import).

Which prime data figures are included in the report? -Market size (Last few years, current and expected)-Market share analysis as per different companies)-Market forecast)-Demand)-Price Analysis)-Market Contributions (Size, Share as per regional boundaries)

Who all can be benefitted out of this report? -Market Investigators-Teams, departments, and companies-Competitive organizations-Individual professionals-Vendors, Buyers, Suppliers-Others

What are the crucial aspects incorporated in the report? -Industry Value Chain-Consumption Data-Market Size Expansion-Key Economic Indicators

Strategic Points Covered in TOC:

Chapter 1: Introduction, market driving force product scope, market risk, market overview, and market opportunities of the global Hemp Derived CBD Oil market.

Chapter 2: Evaluating the leading manufacturers of the global Hemp Derived CBD Oil market which consists of its revenue, sales, and price of the products.

Chapter 3: Displaying the competitive nature among key manufacturers, with market share, revenue, and sales.

Chapter 4: Presenting global Hemp Derived CBD Oil market by regions, market share and with revenue and sales for the projected period.

Chapter 5, 6, 7, 8 and 9: To evaluate the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.

Contact Us:

Web:www.qurateresearch.comE-mail:[emailprotected]Ph: US +13393375221

Follow Us @

LinkedIn

Twitter

Note: In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

More:

Hemp Derived CBD Oil Market 2020 | Business Outlook, Growth, Revenue and Forecasts 2026 | COVID19 Impact Analysis with Top Key Players: CV Sciences,...

BY NOW were used to seeing CBD at the drugstore, in tinctures, capsules, creams and balms. But a growing number of products promise to excite the palate even as they (purportedly) calm the nerves.

Some of the CBD-infused foods and drinks on the market today are exquisite from a gastronomic perspective. Infusion technology has improved, chefs are getting into the game and raising culinary standards, and some makers are leaning into the distinctive piney flavor of the plant instead of trying to mask it. For those curious about CBD as well as experienced consumers wanting to supplement a tincture theyre already taking, there are delicious ways to experiment. I know because I tasted my way through about 50 CBD-infused food and drink items to find the ones worth savoring.

If youre new to CBD, the first thing to know is that it wont get you high. Or, its not likely to. Cannabidiol (CBD for short) is nonintoxicating. But even with CBD extracted from hemp, the variety of the cannabis plant used in all the products listed here, your infused chocolate might, entirely legally, contain up to 0.3% tetrahydrocannabinol (THC), the principal intoxicating compound in cannabis. If you happen to be sensitive, that might just produce a mild psychoactive effect. Plus, both the THC and CBD can add up if youre consuming in quantity. Jamie Evans, author of The Ultimate Guide to CBD, offered this advice: Start low, around 5-10 milligrams [of CBD], and go slow. In other words: This is not Hersheys. Dont eat the entire chocolate bar in one sitting.

The second thing to know about CBD is that nobody knows everything. The limited research currently available can be inconclusive and contradictory. But theres certainly been progress in this space when it comes to flavor.

There are a number of excellent CBD-infused olive oils on the market, for instance, and that makes sense: CBD is extracted from hemp as a thick oil that can be incorporated into another carrier oil relatively easily. Infusing water or a water-based food or drink requires sophisticated and expensive technologya reason some producers prefer to first isolate the CBD in crystalline form. And that can impact efficacy: Its been found that the hundreds of cannabinoid compounds in hempCBD among themwork better in concert with other compounds in the plant known as terpenes, in what some experts term the entourage effect. Or, as Ms. Evans put it: The whole plant is greater than the sum of its parts.

The rest is here:

The Best CBD Brands to Try, From Gummies to Olive Oils - The Wall Street Journal

Oct 1, 2020

Kelly CohenESPN

Danny Colaprico was hurting.

It was 2019, and the 27-year-old midfielder realized that a career in soccer was starting to catch up to her body.

She was introduced to CBD by some of her Chicago Red Stars teammates, and though she was skeptical, she decided to give it a try.

"As it kept growing and CBD got more and more popular, a lot of players in our league started using it," Colaprico told ESPN. "And in my head, I was like, 'OK, I may as well try it out.'"

But what are athletes actually putting in or on their bodies?

2 Related

CBD, short for cannabidiol, is the chemical compound strain of cannabis that can be derived from the hemp or cannabis plant. It has been around for centuries but was not isolated from the plant -- from what causes the "high" -- until 1940 by a team from the University of Illinois. Then, in 2014, the Farm Bill was signed, allowing "institutions of higher education and state agriculture departments to start industrial hemp research and cultivation."

The past few years, CBD has often been touted as a cure-all of sorts. Manufacturers and users claim, mostly anecdotally, that it has given them relief from muscle soreness and swelling and helped curb stress and anxiety. What is actually known or proven by clinical trials is very little.

Hemp-based CBD is legal -- in various forms from ingestible oils to topicals -- in all but three states in the U.S. and is legal at the federal level. States have their own rules restricting or allowing CBD products to be sold, and in many states, CBD can be sold over the counter in drug stores. It remains unregulated by the Federal Drug Administration, however.

Colaprico is allowed to use CBD in the NWSL, but it is currently prohibited in the NFL, NBA, MLB and NHL. In February, MLB and the MLB Players Association announced that they "are working closely with NSF International to develop an independent testing and certification process for" hemp-based CBD products.

The NBA has also expressed interest in revising its bylaws against CBD use. In 2018, CBD was removed from the World Anti-Doping Agency's banned substances list.

Restrictions aside, CBD business is booming. A marketing report released in September found that the global market for CBD oil should grow from $967.2 million in 2020 to $5.3 billion by 2025. That is without CBD brands being allowed to directly advertise their products on social media.

Aaron Keay, chairman of The Alkaline Water Co., thinks the timing is right for athlete endorsements. In May, his company launched a new ingestible CBD product line, including CBD-water, capsules, tinctures and gummies.

"[I]f you look at the kind of the athlete adoption of it, it kind of coincides with how the world is taking it on and looking at it. But you have a few movers and shakers that are willing to take the risk and say: 'Look, CBD is going to become mainstream way ahead of cannabis and THC,'" Keay told ESPN.

It's certainly a business decision on some ends -- for example, Dwyane Wade openly promotes Alkaline's water -- but for others, it is also a health decision.

After nearly two decades on the soccer pitch, Colaprico had a lot of chronic pain, she said. She became more open to trying new ways for her body to recover better and more quickly. CBD, she asserts, became that for her -- and more.

"There are three very useful or beneficial sides to it for an athlete. No. 1, it is a potent anti-inflammatory. No. 2, it helps with sleep. And No. 3, there are lots of reports that show that it helps with anxiety," Dr. Ara Suppiah, a functional sports medicine expert who works with professional athletes, told ESPN.

Because cannabinoids fall under a group of products called adaptogens -- think of herbs such as ashwagandha, Rhodiola and ginseng -- they are able to give users the same benefits, Suppiah said. (Adaptogens, some research suggests, help your body deal with stress and have become more popular in recent years.)

Suppiah is PGA player Bubba Watson's doctor and has been vocal in encouraging the golfer to use CBD to alleviate the trouble he has sleeping before a final round.

"So for an athlete, if you're looking for the ability to recover and perform over and over again, it is a useful tool in the toolbox," Suppiah said.

That rings true for Colaprico, who says she can also feel the benefits of CBD on her high levels of stress and anxiety.

All of these claimed benefits come with cautions, especially because there is very little scientific evidence to back the purported advantages of CBD. The FDA lists a handful of potential harms, side effects and unknowns about CBD and believes that "[s]ome CBD products are being marketed with unproven medical claims and are of unknown quality."

But because much is still unknown about how CBD is delivered to the brain and how much of what is in the product goes elsewhere in the body, critics are concerned. For instance, the absorption and processing of CBD by a 12-year-old athlete and a 200-pound professional athlete are likely to be different.

"The FDA has seen only limited data about CBD safety, and these data point to real risks that need to be considered before taking CBD for any reason," the agency said in November.

Dr. Krista Lisdahl, the director of the University of Wisconsin-Milwaukee's Brain Imaging and Neuropsychology Laboratory, says she cannot recommend CBD usage to anyone for any of the issues its makers and sellers claim that it can address.

That, she told ESPN, is because of the lack of clinical trials that prove -- or disprove -- benefits and potential side effects. So far, in an evaluation study of CBD as a dietary supplement, there has been only evidence proving that CBD has anti-inflammatory properties in animals, with "some human evidence that it can reduce some of that inflammation."

"There needs to be more large-scale clinical trials where we can confirm that CBD is, in fact, effective. So, for example, there have been a couple of clinical trials where we use a placebo-controlled, double-blinded design, where people are getting CBD or getting a placebo and they don't know which one they get, and then you actually test the effects of CBD on sleep in an objective way," said Lisdahl, who studies the neuroscience of addiction and drug effects. "Those studies have not found a significant effect on sleep and on healthy people."

Right now, the scientific evidence for sleep is only low-level, suggesting that CBD might increase sleepiness or decrease the time it takes for a person to fall asleep, she explained.

Further, there is no "direct evidence" in athletes to suggest that CBD helps muscle recovery and sport performance, Lisdahl said. Athletes who claim those benefits are promoting their "objective experience," she said, something that is neither proven nor disproven by science.

Those in the CBD industry hope that FDA approval will come sooner rather than later, especially because in 2018, the agency approved a prescription form of CBD for the treatment of two rare and severe forms of epilepsy. In late July, the FDA approved CBD for use in treating another seizure disorder, tuberous sclerosis complex.

If that approval happens, the industry's relationship with sports is bound to grow.

"[I]t'll probably get the stamp from the FDA and lawmakers, I'm guessing maybe within this election year or within the calendar year. I think you'll really start to see movement there, and that's why the athletes are starting to come out and get way more supportive than they ever were," Keay told ESPN.

The FDA in March said that it had "embarked on a comprehensive evaluation of [CBD] products, with a focus on educating the public about the risks and unknowns of these products, gathering the science needed to better understand both these safety concerns and potential benefits to inform our regulatory approach."

The FDA went on to state that it "recognize[s] the significant public interest in CBD and we must work together with stakeholders and industry to develop high-quality data to close the substantial knowledge gaps about the science, safety, and quality of many of these products."

Jay Hartenbach, the CEO of Medterra CBD, has found a handful of athlete endorsers, who are listed on the company's website, for his products outside of mainstream sports, such as surfers, cyclists and volleyball players. He says he has seen growth in three years that he "can't imagine" in another industry.

"The professional athletes, for us, are twofold: One, to just get general awareness and two, it's to show the league: 'Your athletes are supporting it. Why are you holding this back from your players?'" he said.

The endorsements and claims are appealing, especially for someone seeking pain relief or a restful night's sleep. But the message from those outside the CBD industry? Athlete recommendations do not trump medical ones.

Lisdahl told ESPN that she understands why CBD is "attractive" both to use and to promote.

"CBD is considered safe for the most part. People aren't going to experience a lot of negative side effects," she said. "So I could certainly see why people would try it. It is relatively cheap compared to the other interventions available to them."

But there are other proven treatments to help with muscle soreness, inflammation, stress and anxiety and to help athletes sleep better, she said.

"I personally wouldn't recommend CBD for any indications right now because it's not passing any of the clinical trials," Lisdahl said.

More:

The CBD business is booming, but little is known about the actual benefits - ESPN

Cannabidoil, or CBD, is derived from the hemp plant, a relative of the marijuana plant. CBD oil has seen a surge in popularity in the recent years among customers who use it for treating various conditions such as anxiety, insomnia and chronic pain. However, its growing popularity comes with many questions for employers.[1]At times, CBD oil can contain traces of THC, which is considered a controlled substance, and can result in positive drug tests. However, CBD oil by itself does not usually cause a high. CBD oil is legal in all 50 states with varying degrees of restrictions, but its legality will likely change over the coming years. There is very little guidance from the courts on whether employers should accommodate CBD use when creating their drug policy.

In Pennsylvania, an employer sought judicial review of an unemployment order that held the employee was not ineligible for unemployment compensation after the employee admitted to use of CBD oil, tested positive for marijuana and was terminated.[2]The employer had a policy providing that being under the influence of drugs or having drugs in ones system while at work was ground for termination. The policy defined drug as any substance producing effects on the central nervous system, or any controlled substance. The employee disclosed she took CBD oil to manage her cancer-related symptoms before being administered the drug test. The court found the employee did not violate the drug policy because the CBD oil ingested was not a controlled substance, and the employer presented no evidence the oil ingested would affect the employees performance in ways prohibited by the policy.

In North Carolina, a woman was fired from her job for using an over-the-counter CBD oil after a drug test revealed THC in her system.[3]The woman used CBD oil to treat chronic pain from fibromyalgia, which had been cleared by her rheumatologist and disclosed to her employer.

In a lawsuit claiming wrongful termination and damages, the woman noted that the low levels of THC did not meet the threshold level of being impaired under federal Department of Transportation regulations. The lawsuit claims that due to the low amounts of THC, the woman tested negative for purposes of driving a commercial vehicle and was not impaired.[4]The court held that CBD oil is a legal product under North Carolina law, even if it contains small amounts of THC that would otherwise be considered a controlled substance.

Court decisions such as these create a great deal of questions for employers and their drug policies. Should employers who have a zero-tolerance drug policy accommodate employees who use CBD products? What should an employer do if an employee tests positive on a drug test and blames the use of CBD products which are legal? Does the level of THC in an employees system have any weight on an employers decision to terminate? The answer to these questions will continue to evolve as we learn more about CBD products. Like many other states, North Carolinas laws are likely to evolve as we learn more about CBD.

While many CBD products do not contain enough THC to result in a positive drug test, CBD products are not regulated in the U.S., which means there is no way to ensure THC levels remain low in products. Employers should educate employees on this issue and carefully examine the CBD and controlled substances laws in their jurisdiction. Handling positive drug tests where an employee blames the use of a legal CBD product may need to be evaluated on a case-by-case basis. Employers should consult with their employment attorney before revising their drug policy.

[1]Peter Grinspoon,Cannabidiol (CBD) What We Know and What We Dont, Harvard Health Publishing, https://www.health.harvard.edu/blog/cannabidiol-cbd-what-we-know-and-what-we-dont-2018082414476 (last visited Sep. 30, 2020).

[2]Washington Health Sys. v. Unemployment Comp. Bd. of Review, 231 A.3d 79 (Pa. Commw. Ct. 2020).

[3]Joe Marusak,Woman Used Over-the-Counter Oil to Treat Chronic Pain. It got her Fired, Lawsuit says,The Charlotte Observer, https://www.charlotteobserver.com/article232244097.html (last visited Sep. 30, 2020).

[4]Smith v. Manheim Remarketing, Inc et al, No. 5:19CV00086 (W.D.N.C. Nov. 25, 2019).

Read this article:

CBD Oil & Its Implication on Drug Policies in the Workplace - JD Supra

PALM BEACH, Fla., Oct. 1, 2020 /PRNewswire/ --The global CBD and CBD oil market revenues are projected to continue to rise significantly in the coming years. Increasing consumer preference for various cannabidiol infused products such as capsules, cannabis oil, beverages, beauty and skincare products, gummies, and dog treats is further anticipated to drive the CBD oil and CBD consumer health market. Cannabidiol can enter the body in several ways such as vaping, ingesting, smoking, and through the skin. Growing adoption of cannabidiol to manufacture medical drugs and personal care products in states where cannabis is legal is positively impacting the market growth. The legalization of cannabis-based products has provided a remarkable opportunity for the end-user industries to expand. The growing number of research activities, increasing awareness regarding synthetic cannabidiol, and rising strategic investments by companies are expected to contribute to the overall growth through 2027. Mentioned in today's commentary includeAurora Cannabis Inc.(NYSE: ACB) (TSX: ACB), Sativa Wellness Group Inc. (CSE: SWEL), Naturally Splendid Enterprises Ltd.(TSXV: NSP) (OTCQB: NSPDF), Aphria Inc. (NASDAQ: APHA) (TSX: APHA), Namaste Technologies Inc.(TSXV: N) (OTCQB: NXTTF).

Reports from Grand View research have addressed both the CBD and CBD oil markets in optimistic reports. One such report said that the global cannabidiol market was valued at USD 4.6 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 22.2% from 2019 to 2025. The demand for cannabidiol (CBD) for medical and wellness purposes is high due to its healing properties, which is the key factor driving the growth of the market. Moreover, growing product adoption and utilization owing to government approvals is a major factor anticipated to drive the demand for cannabidiol infused products. Cannabidiol has become the latest consumer trend, which is a result of the increasing number of social media influencers promoting the benefits of cannabis, marketing initiatives by the industry participants, and growing application areas. Subsequently increasing product options such as skincare, cosmetics, haircare, intimate lubricants, pharmaceuticals, gummies, pills, infused beverages, and other products are also driving the market for cannabidiol.

Sativa Wellness Group Inc. (CSE:SWEL) Breaking News: Sativa Wellness Group Inc. (previously, Stillcanna, Inc.) Announces Closing of Transaction with Sativa Group Plc. and Resumption of Trading on the Canadian Securities Exchange - Sativa Wellness Group Inc. (formerly, Stillcanna Inc.) (CSE:SWEL) ("Sativa" or the "Company") is pleased to announce that further to news releases dated September 10, 2020 and September 18, 2020, following the closing of the Company's acquisition, through a scheme of arrangement, of Sativa Group Plc (the "Transaction") the common shares of the Company will resume trading on the Canadian Securities Exchange ("CSE") at the market open on September 30, 2020. Trading will resume on the CSE under the new symbol "SWEL". The Company will be listed for trading on the AQSE Growth Market (the "AQSE") in the United Kingdom (the "UK") on Thursday, October 1, 2020 under the new symbol "SWEL" and expects to be quoted on the over-the-counter (the "OTC") market in the United States and the Frankfurt Stock Exchange (the "FSE") shortly.

The Company would like to sincerely thank shareholders for their patience and support during the trading halt. The Transaction was subject to requisite legislative and exchange regulatory approvals in both the United Kingdom and Canada.

Going forward, Sativa is now a true vertically-integrated European seed-to-consumer cannabidiol ("CBD") wellness company. The Company manages the cultivation of raw materials, owns extraction, packaging and testing facilities, and has developed and marketed leading consumer brands. This complete supply chain custody model ensures that retail and wholesale customers receive pharmaceutical grade CBD products they can trust.

"We are thrilled to have completed the process of combining our two businesses to form a leading European CBD Wellness company", stated Henry Lees-Buckley, CEO of Sativa. "Discerning consumers demand very high quality and compliant products and we believe the best way to ensure the Company is able to fulfill this demand is to have management control throughout the entire production, manufacturing and distribution process. The regulatory environment in the UK and Europe are also rightly demanding companies achieve new compliance standards such as the UK FSA Novel Foods accreditation. We expect our products will be validated by the UK FSA by the March 2021 deadline," added Henry.

In addition to the commercial operating activities, a wholly owned subsidiary "Sativa Cultivation and Extraction Ltd" holds a Controlled Drug License for the cultivation, production and possession of high THC content cannabis in the UK for medical research as part of the Company's partnership agreement with King's College London to research the impact of cannabinoids on inflammation and respiratory conditions. Read more news announcements for SWELat: https://sativawellnessgroup.com/category/press-releases/

In other active company news in the markets this week:

Aurora Cannabis Inc.(NYSE :ACB) (TSX: ACB) recently announced its financial and operational results for the fourth quarter of fiscal 2020 endedJune 30, 2020. "As reported in ourSeptember 8, 2020business update, our Q4 demonstrated progress in rationalization of SG&A and cash burn along with continued leadership in both Canadian and international medical. However, Aurora has slipped from its top position in Canadian consumer, a market that continues to support material growth and opportunity," statedMiguel Martin, recently appointed Chief Executive Officer of Aurora. "My focus is therefore to re-position the Canadian consumer business immediately. We look to expand beyond the value flower segment, leverage our capabilities in science and product innovation and put our effort on a finite number of emerging growth formats. This entails prioritizing our San Rafael, Aurora and Whistler premium brands in flower, pre-rolls and vapor, which will be shortly followed by strategic marketing and innovation efforts in concentrates and edibles."

Naturally Splendid Enterprises Ltd.(TSXV: NSP) (OTCQB: NSPDF) recently announced they have signed an exclusive sales and distribution agreement for an extensive line of plant-based, meat alternative products, with one of Australia's most popular plant-based manufacturers.Naturally Splendid has come to terms with BettaLife Global Food Solutions of Australia for the exclusive sales and distribution rights for Canada, for a wide range of plant-based, meat alternative products. The Company has also been granted sales and distribution rights to access the United States market.

Additionally, Naturally Splendid has confirmed adequate line processing time with the manufacturer to meet current needs into Q2 of 2021. The companies have begun discussions on building out a manufacturing facility in Canada to meet anticipated consumer demand for these market disrupting products.

Aphria Inc. (NASDAQ: APHA) (TSX: APHA), a leading global cannabis company, recently announced it has entered into a Strategic Supply Agreement (the"Agreement") with Canndoc Ltd. ("Canndoc"), a subsidiary of InterCure Ltd., one ofIsrael'slargest and most established medical cannabis producers.Under the terms of the Agreement, Aphria will supply Canndoc with dried bulk flower over a two-year period, with the option to extend for two additional terms of two years each, and an option for an additional year after that if the parties agree to terms.During the first two-year term and each additional term, if applicable, the Company will provide Canndoc with 3,000 kgs. of bulk dried flower, which will be processed into finished product, co-branded under the Aphria and Canndoc brand names, and sold exclusively within the Israeli market.

Namaste Technologies Inc.(TSXV: N) (OTCQB: NXTTF), a leading online platform for cannabis products, accessories, and responsible education, recently provided a corporate update with regards to a change in management and the settlement of an outstanding claim to the benefit of Company shareholders.

The Company is pleased to announce the appointment ofSlava Klems, CPA, CA, as interim chief financial officer as ofOctober 31, 2020. Ms. Klems succeedsAnnie Holmeswho is leaving Namaste to pursue other opportunities, concluding her role as chief financial officer onOctober 30, 2020.

"I would like to welcome Ms. Klems to the position of interim chief financial officer for Namaste," saidMeni Morim, CEO of Namaste Technologies. "She has an impressive background in corporate finance with experience in technology and platform integration and has shown an incredible business acumen since joining the Company. I look forward to working with Ms. Klems as we seek to drive Namaste forward. Additionally, I would like to thank Ms. Holmes for her work at Namaste and her assistance with the seamless transition to Ms Klems over the next few weeks."

DISCLAIMER: FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third- party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.FNM is NOT affiliated in any manner with any company mentioned herein.FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.FNM's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.FNM is not liable for any investment decisions by its readers or subscribers.Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.For current services performed FNM was compensated twenty six hundred dollars for news coverage of current press release issued by Sativa Wellness Group Inc. by a non affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Contact Information:Media Contact email: [emailprotected]+1(561)325-8757

SOURCE Financialnewsmedia.com

Read the original here:

Growing Adoption of CBD Pharmaceutical Grade and Wellness Products Having Healthy Impact on Market Growth - PRNewswire